28 January 2022 · Guidance on interacting drugs to be used alongside the NHSE/I commissioning policy for Paxlovid®, containing PF-07321332 (nirmatrelvir) and ritonavir.
20 December 2021 · Three models exist for the supply and administration of COVID-19 treatments through CMDUs. We guide through the risks and mitigations associated with each.
20 December 2021 · Chief Pharmacists may need to oversee and manage prescription and supply of nMABs and oral antivirals in CMDUs. Use our framework and resources to help.
15 December 2021 · Deployment should address a range of factors and be implemented through different mechanisms. Collecting data and learning will support continued safe use.
14 December 2021 · This guidance for Chief Pharmacists supports the pharmacy institutional readiness for the management of sotrovimab in COVID-19 infection.